Phenobarbitone versus phenytoin monotherapy for epilepsy: an individual participant data review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Phenobarbitone Versus Phenytoin Monotherapy for Epilepsy: an Individual Participant Data Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439919/all/Caffeine_dosing_regimens_in_preterm_infants_with_or_at_risk_for_apnea_of_prematurity_New. Accessed 29 March 2024.
Phenobarbitone versus phenytoin monotherapy for epilepsy: an individual participant data review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439919/all/Caffeine_dosing_regimens_in_preterm_infants_with_or_at_risk_for_apnea_of_prematurity_New. Accessed March 29, 2024.
Phenobarbitone versus phenytoin monotherapy for epilepsy: an individual participant data review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439919/all/Caffeine_dosing_regimens_in_preterm_infants_with_or_at_risk_for_apnea_of_prematurity_New
Phenobarbitone Versus Phenytoin Monotherapy for Epilepsy: an Individual Participant Data Review [Internet]. In: Cochrane Abstracts. [cited 2024 March 29]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439919/all/Caffeine_dosing_regimens_in_preterm_infants_with_or_at_risk_for_apnea_of_prematurity_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Phenobarbitone versus phenytoin monotherapy for epilepsy: an individual participant data review
ID - 439919
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439919/all/Caffeine_dosing_regimens_in_preterm_infants_with_or_at_risk_for_apnea_of_prematurity_New
DB - Evidence Central
DP - Unbound Medicine
ER -